[ET Net News Agency, 20 August 2021] AKESO-B (09926) fell 9.06% to HK$36.15.
It hits an intra-day low of HK$35.75, hitting an 1-month low, and an intra-day high of
HK$39.35. The total shares traded was 2.8 million, with a value of HK$103.07m. The active
buy/sell ratio is 46:54, with net selling turnover of HK$7.3m. MORGAN STANLEY HK SEC
accounts for greatest net responsive buying turnover of HK$10.5m, with volume weighted
average price of HK$36.644. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive
selling turnover of HK$11.63m, with volume weighted average price of HK$36.672. The stock
has fallen a combined 18.4% over the past 5 consecutive trading days.
The Hang Seng Index now fell 265 points, or 1.05% to 25,050; the Hang Seng China
Enterprises Index now fell 89 points, or 1% to 8,826; the Hang Seng TECH Index now fell 66
points, or 1.1% to 5,977; with an overall turnover of HK$58.77b.
The SSE Composite Index now fell 28 points, or 0.81% to 3,437, with an overall turnover
of RMB222.61b.
The SZSE Component Index now fell 132 points, or 0.91% to 14,355, with an overall
turnover of RMB140.9b.
Basic Information
-------------------------------------------
Nominal 36.150 % Chg -9.06%
High 39.350 Low 35.750
Shares Tr 2.8m Turnover 103.07m
10-D SMA 43.600 %H.V 64.378
20-D SMA 46.258 VWAP 36.763
50-D SMA 54.266 RSI14 23.991
-------------------------------------------
Status: Hitting an 1-month low, active buy/sell ratio is 46:54, with net selling
turnover of HK$7.3m, falling a combined 18.4% over the past 5 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
AKESO-B (09926) 36.15 -9.06
GENSCRIPT BIO (01548) 32.50 -6.34
INNOVENT BIO (01801) 62.20 -7.44
JXR (01951) 11.80 -2.64
WUXI BIO (02269) 105.30 -7.47
BEIGENE (06160) 161.90 -5.43
CANSINOBIO-B (06185) 268.40 -5.43
ALPHAMAB-B (09966) 17.46 -5.42
INNOCARE-B (09969) 20.55 -6.38
REMEGEN-B (09995) 96.80 -5.47
-------------------------------------------------
(ed)